Healthcare Sales & Marketing Network News: palivizumab

Searching News Database: palivizumab

HSMN NewsFeed - 13 Nov 2018
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 20 Dec 2007
MedImmune Expands Scientific and Engineering Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2007
New Study in Journal of Pediatrics Suggests Synagis(R) (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
Biopharmaceuticals

HSMN NewsFeed - 8 May 2007
MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
Biopharmaceuticals

HSMN NewsFeed - 20 Feb 2007
MedImmune Further Expands its Commercial Organization Expertise With Appointment of Two Additional Vice Presidents
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Feb 2007
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Nov 2006
Numax(R) Achieves Primary Endpoint In Preliminary Analysis of Data From Comparative Phase 3 Trial With Synagis(R)
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
MedImmune Fills Senior Marketing and Sales Post
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 22 additional stories matching:
palivizumab
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.